CBR Pharma Insights
CBR Pharma Insights Market Research Reports
| Title | published | price | |
|---|---|---|---|
Emerging Gene Therapies - Trends within the Technological, Clinical, Regulatory and Competitive LandscapeBy CBR Pharma Insights
Emerging Gene Therapies - Trends within the Technological, Clinical, Regulatory and Competitive Landscape Summary GBI Research's latest report "Emerging Gene Therapies - Trends within the Technological, Clinical, Regulatory ... |
03-Jan-2019 | $2995 | |
Global Biosimilars Market - Increasingly Lucrative Market Fueled by Constrained Payer Environment and Patent Expiries for Best-Selling BiologicsBy CBR Pharma Insights
Global Biosimilars Market - Increasingly Lucrative Market Fueled by Constrained Payer Environment and Patent Expiries for Best-Selling Biologics Summary GBI Research's latest report: "Biosimilars" provides an in-depth assess ... |
01-Jan-2019 | $2995 | |
Global Clinical Trials - Current Trends and Recent AdvancementBy CBR Pharma Insights
Global Clinical Trials - Current Trends and Recent Advancement Summary GBI Research's latest report, Global Clinical Trials - Current Trends and Recent Advancement, provides an in-depth assessment of the current trends in th ... |
01-Jan-2019 | $2995 | |
Innovation Tracking Factbook 2018: An Assessment of the Pharmaceutical PipelineBy CBR Pharma Insights
Innovation Tracking Factbook 2018: An Assessment of the Pharmaceutical Pipeline Summary GBI Research's latest report "Innovation Tracking Factbook 2018: An Assessment of the Pharmaceutical Pipeline" is a comprehensive, granu ... |
14-Dec-2018 | $2995 | |
Exosome Technologies: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key PlayersBy CBR Pharma Insights
Summary GBI Research’s latest report, Exosome Technologies: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key Players, explores the application of exosome technologies within the pharmaceu ... |
12-Oct-2018 | $2995 | |
PI3K Signaling Pathway Analysis: A Shifting Marketed and Pipeline Product Landscape, as Blockbusters Expire and Development Moves Towards Downstream TargetsBy CBR Pharma Insights
PI3K Signaling Pathway Analysis: A Shifting Marketed and Pipeline Product Landscape, as Blockbusters Expire and Development Moves Towards Downstream Targets Summary GBI Research's latest report, PI3K Signaling Pathway Analys ... |
01-Jul-2018 | $2995 | |
The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key PlayersBy CBR Pharma Insights
GBI Research’s latest report, The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players, provides an in-depth assessment of the current trends in the global mid-size pharma market, a ... |
04-May-2018 | $2995 | |
Artificial Intelligence Technologies: Market Prospects - Featuring Expert Panel Views from Industry Survey 2018By CBR Pharma Insights
GBI Research’s latest report: “Artificial Intelligence Technologies: Market Prospects - Featuring Expert Panel Views From Industry Survey 2018” considers the current and future impact of artificial intelligence (AI) technologies ... |
30-Mar-2018 | $2995 | |
Cosmeceuticals: Global Trends in Market Entry Strategies, Regulatory Framework, Next-Generation Products and TechnologiesBy CBR Pharma Insights
Summary Latest report, Cosmeceuticals: Global Trends in Market Entry Strategies, Regulatory Framework, Next-Generation Products and Technologies, provides an in-depth assessment of the current trends in the global cosmeceu ... |
01-Feb-2018 | $2995 | |
Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products such as Glybera and StrimvelisBy CBR Pharma Insights
Summary “Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products such as Glybera and Strimvelis” dis ... |
01-Feb-2018 | $2995 | |
- + 1 888 391 5441
- [email protected]
